title: Malignant Mesothelioma Mortality - United States, 1999-2015.
abstract: Malignant mesothelioma is a neoplasm associated with occupational and environmental inhalation exposure to asbestos* fibers and other elongate mineral particles (EMPs) (1-3). Patients have a median survival of approximately 1 year from the time of diagnosis (1). The latency period from first causative exposure to malignant mesothelioma development typically ranges from 20 to 40 years but can be as long as 71 years (2,3). Hazardous occupational exposures to asbestos fibers and other EMPs have occurred in a variety of industrial operations, including mining and milling, manufacturing, shipbuilding and repair, and construction (3). Current exposures to commercial asbestos in the United States occur predominantly during maintenance operations and remediation of older buildings containing asbestos (3,4). To update information on malignant mesothelioma mortality (5), CDC analyzed annual multiple cause-of-death records†for 1999-2015, the most recent years for which complete data are available. During 1999-2015, a total of 45,221 deaths with malignant mesothelioma mentioned on the death certificate as the underlying or contributing cause of death were reported in the United States, increasing from 2,479 deaths in 1999 to 2,597 in 2015 (in the same time period the age-adjusted death rates§decreased from 13.96 per million in 1999 to 10.93 in 2015). Malignant mesothelioma deaths increased for persons aged ≥85 years, both sexes, persons of white, black, and Asian or Pacific Islander race, and all ethnic groups. Despite regulatory actions and the decline in use of asbestos the annual number of malignant mesothelioma deaths remains substantial. The continuing occurrence of malignant mesothelioma deaths underscores the need for maintaining measures to prevent exposure to asbestos fibers and other causative EMPs and for ongoing surveillance to monitor temporal trends.
authors.forename: Jacek M
authors.initials: JM
authors.lastname: Mazurek
authors.forename: Girija
authors.initials: G
authors.lastname: Syamlal
authors.forename: John M
authors.initials: JM
authors.lastname: Wood
authors.forename: Scott A
authors.initials: SA
authors.lastname: Hendricks
authors.forename: Ainsley
authors.initials: A
authors.lastname: Weston
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001194:Asbestos / Q000633:toxicity; D002423:Cause of Death; D005260:Female; D006801:Humans; D019570:Inhalation Exposure / Q000009:adverse effects; D008175:Lung Neoplasms / Q000209:etiology / Q000401:mortality*; D008297:Male; D008654:Mesothelioma / Q000209:etiology / Q000401:mortality*; D000086002:Mesothelioma, Malignant; D008875:Middle Aged; D019016:Mineral Fibers / Q000009:adverse effects; D009784:Occupational Diseases / Q000209:etiology / Q000401:mortality; D016273:Occupational Exposure / Q000009:adverse effects; D014481:United States / Q000453:epidemiology
chemical_list: D019016:Mineral Fibers; D001194:Asbestos